Will the promise of data to enhance patient outcomes and help the NHS through Covid-19 recovery come true?
Accountable Care Journal
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 67,000 employees worldwide.
Webinar Report Part Two – Unleashing the potential of global Britain for life sciences: Leading innovation, access and uptake.
World Pharmaceutical and Biotech Journal
Webinar report Part One - Unleashing the potential of global Britain for life sciences: Leading innovation, access and uptake.
World Pharmaceutical and Biotech Journal
Part Three: Before we are patients, we are people. IQVIA and Public Policy Projects convened a virtual summit of experts to discuss developments in genomics and precision medicine in the context of unleashing the potential of global Britain for life sciences
World Pharmaceutical and Biotech Journal
Part Two: Driving change through NHS infrastructure. IQVIA and Public Policy Projects convened a virtual summit of experts to discuss developments in genomics and precision medicine in the context of unleashing the potential of global Britain for life sciences
World Pharmaceutical and Biotech Journal